NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Quick Ratio in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary: NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Quick Ratio history and growth rate from Q1 2022 to Q2 2024.
NEUROONE MEDICAL TECHNOLOGIES Corp Quick Ratio for the quarter ending June 30, 2024 was 101 %, a 80.8% increase year-over-year.

Quick Ratio, Quarterly (%)

Quick Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	101	+44.9	+80.8%	Jun 30, 2024
Q1 2024	95.4	+47.7	+100%	Mar 31, 2024
Q4 2023	93.1	+55.4	+147%	Dec 31, 2023
Q3 2023	82.8	+55	+198%	Sep 30, 2023
Q2 2023	55.6	+29.7	+114%	Jun 30, 2023
Q1 2023	47.6	+31.8	+201%	Mar 31, 2023
Q4 2022	37.7			Dec 31, 2022
Q3 2022	27.8			Sep 30, 2022
Q2 2022	25.9			Jun 30, 2022
Q1 2022	15.8			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.